Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 20 May 2024, 17:03 HKT/SGT
Share:
        

Source: Paw Pro GmbH / Health Reasoning
Paw Pro GmbH Announces $1.5M Partnership with Health Reasoning to Launch Innovative Web3 Platform

Nashville, TN, May 20, 2024 - (ACN Newswire) - Paw Pro GmbH, a leader in Pet Health, is thrilled to announce a $1.5 million partnership with Health Reasoning, a pioneer in Healthcare AI and tokenization. This strategic collaboration aims to develop and deploy an innovative Web3 platform featuring the revolutionary Treats token and redeemable NFTs.

The partnership highlights the growing synergy between Paw Pro’s vision for enhanced customer engagement and Health Reasoning’s expertise in blockchain technology. This collaboration is poised to deliver a state-of-the-art digital ecosystem that will redefine user interaction and reward mechanisms within Paw Pro’s community.

Platform Features:

Treats Token: A blockchain-based utility token designed for transactions, rewards, and incentives within the Paw Pro ecosystem uniting all pet lovers. Detailed information about the Treats token will be available in an upcoming white paper.

Redeemable NFTs: Unique digital assets that users can acquire, trade, and redeem for various rewards, enhancing user engagement and loyalty.

“We are excited to partner with Health Reasoning to bring cutting-edge blockchain technology to our platform,” said Katrina Graue, CEO of Paw Pro GmbH. “This collaboration will not only enhance our service offerings but also provide our users with innovative ways to interact with and benefit from our ecosystem.”

“Health Reasoning is thrilled to join forces with Paw Pro GmbH in this transformative project,” said Damon Spiceland, CEO of Health Reasoning. “Our expertise in AI and Blockchain technology combined with Paw Pro’s vision for customer engagement will set a new standard in the industry.”

This partnership underscores Paw Pro’s commitment to leveraging advanced technologies to provide unparalleled value to its users. The development and integration of the Web3 platform will begin immediately, with the first phase of the project expected to launch this summer.

For more information about Paw Pro GmbH and Health Reasoning, please visit https://paw-pro.com/ and https://healthreasoning.com/.

About Paw Pro GmbH

Paw Pro GmbH is a leading innovative company in bacteria-based nutrition supplements for dogs, dedicated to improving the well-being of pets through advanced solutions and exceptional care. At PawPro, we offer natural and chemical-free pet supplements, especially created to protect pets, helping them strengthen their immune system for a long, happy life. Our patented combination of elements, sourced from the highest quality ingredients, ensures that our products are unique and highly effective. We produce our supplements at a state-of-the-art medical research center in Germany. Paw Pro’s vision is to become one of the leading pet supplement brands in the market, meeting and exceeding the standards of our clients by providing them with healthy and natural products for their pets. We aim to protect dogs, supporting their natural immune system and improving their lifestyle as a result.

About Health Reasoning

Health Reasoning is a pioneering company in Healthcare, specializing in blockchain and artificial intelligence solutions that drive transformation and efficiency. Health Reasoning’s mission is to harness the power of blockchain technology to create secure, transparent, and user-centric digital ecosystems.

Media Contacts:

Paw Pro GmbHKatrina Graue
CEO
Katrina.graue@paw-pro.com
+49 155 61687211

Health Reasoning
Damon Spiceland
Chief Executive Officer
damon@healthreasoning.com
615-218-7594




Topic: Press release summary
Source: Paw Pro GmbH / Health Reasoning

Sectors: Blockchain Technology
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
MarketingPulse and eTailingPulse open next Thursday  
Mar 11, 2026 16:54 HKT/SGT
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD(TM) 2026 Annual Meeting   
Wednesday, March 11, 2026 11:07:00 AM
JOYY Reports 4Q and FY2025 Financial Results: Q4 Revenue Returns to YoY Growth, BIGO Ads Up 61.5% YoY  
Mar 11, 2026 09:40 HKT/SGT
Kincora Consolidates, Commences Geophysics and Forms Partnership at Cowal East  
Mar 10, 2026 17:59 HKT/SGT
Fosun Navigates Cyclical Volatility and Clears Risks as Management Reaffirms RMB10 Bn Profit Target for Next 3 to 5 Yrs  
Mar 10, 2026 15:45 HKT/SGT
Impro Precision 2025 Profit Attributable to Shareholders Reaches Record High of HK$726.2 Million, Up 12.7% Year-on-Year, Forecast 2026 Sales Growth Rate to Accelerate to Mid-Double Digits  
Mar 10, 2026 14:19 HKT/SGT
Natural Beauty's 2025 Annual Results Show Steady & Robust Growth  
Mar 10, 2026 13:35 HKT/SGT
Xiamen C&D Inc.'s New Five-Year Strategic Plan Released, Aiming to Accelerate Globalization  
Mar 10, 2026 12:30 HKT/SGT
Fujitsu launches Japan's first defense tech open innovation program  
Tuesday, March 10, 2026 10:45:00 AM
Entertainment Expo Hong Kong shines on the centre stage, Eight signature events unite global film and entertainment forces  
Mar 9, 2026 20:04 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: